Predict your next investment

Clover Biopharmaceuticals company logo
HEALTHCARE | Biotechnology

See what CB Insights has to offer

Founded Year



Series C - II | Alive

Total Raised


Last Raised

$38.07M | 6 mos ago

About Clover Biopharmaceuticals

Clover Biopharmaceuticals is a biotechnology company focused on developing novel and transformative biologic therapies, with a focus on oncology and autoimmune diseases.

Clover Biopharmaceuticals Headquarter Location

B-A10 Room No.1, Mansion, Chengdu Hi-tech Zone, Hi-tech Incubation Park Tianhe Incubator, Nan Yan Xian Tian Fu Avenue

Chengdu, Sichuan, 610041,


Latest Clover Biopharmaceuticals News

New Chinese vaccine proves 67 pct effective against COVID-19, 79 pct against Delta variant in clinical trial: report

Sep 26, 2021

News Snapshot: A new COVID-19 vaccine developed by China's Clover Biopharmaceuticals has proven to be 67 percent effective against COVID-19, and 79 percent against the Delta variant in a mass clinical trial, Reuters reported recently. The vaccine "was 67 percent effective against COVID-19 of any degree of severity and 79 percent against the highly infectious Delta variant in a large trial," the international news organization said in a report published Wednesday, citing Clover's statement. Besides, the vaccine was 83.7 percent effective against moderate-to-severe cases in the trial, and in particular, 81.7 percent effective against those moderate-to-severe cases caused by Delta, the report...

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Clover Biopharmaceuticals

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Clover Biopharmaceuticals in 1 CB Insights research brief, most recently on Aug 5, 2021.

Expert Collections containing Clover Biopharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Clover Biopharmaceuticals is included in 4 Expert Collections, including Pharma Startups.


Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.



14,138 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.



3,604 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.


Infectious Disease

2,267 items

Entities aiding the surveillance, screening, prevention, diagnosis, treatment, and containment of infections & the maintenance of public wellbeing during outbreaks.

Clover Biopharmaceuticals Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Clover Biopharmaceuticals Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.